Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28483386 | 1.00 | THRB (0.39) | THRBLMNA | |
| SCHEMBL28552565 | 1.00 | THRB (0.39) | THRBLMNA | |
| SCHEMBL9667909 | 1.00 | THRB (0.39) | THRBLMNA | |
| SCHEMBL9397432 | 0.95 | — | — | |
| SCHEMBL4077977 | 0.95 | — | — | |
| SCHEMBL14701182 | 0.77 | THRB (0.38) | THRBLMNA | |
| SCHEMBL13679262 | 0.77 | THRB (0.38) | THRBLMNA | |
| SCHEMBL23425446 | 0.73 | THRB (0.35) | THRBLMNA | |
| SCHEMBL17685112 | 0.72 | — | — | |
| SCHEMBL18530024 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113260635-B | Oligosaccharide compositions and methods of use thereof | DSM营养产品有限责任公司 | 2023-10-31 | — | — | CN | claimed |
| CN-113056488-B | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM营养产品有限责任公司 | 2023-10-24 | — | — | CN | claimed |
| CN-114901081-A | Malonyl steviol glycosides and edible use thereof | 弗门尼舍有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-114343159-A | Malonyl steviol glycosides and edible use thereof | 弗门尼舍有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-113260635-A | Oligosaccharide compositions and methods of use thereof | 卡莱多生物科技有限公司 | 2021-08-13 | — | — | CN | claimed |
| US-20240216417-A1 | Use of Polysaccharide for Treating ST-Elevation Myocardial Infarction and Diseases of the Digestion System | PT. Sahabat Lingkungan Hidup (ID) | 2024-07-04 | — | — | US | disclosed |
| CN-113260635-B | Oligosaccharide compositions and methods of use thereof | DSM营养产品有限责任公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-113056488-B | Oligosaccharide compositions and methods of use thereof for reducing ammonia levels | DSM营养产品有限责任公司 | 2023-10-24 | — | — | CN | disclosed |
| US-11766450-B2 | Use of polysaccharide for treating ST-elevation myocardial infarction and diseases of the digestion system | PT. Sahabat Lingkungan Hidup (ID) | 2023-09-26 | — | — | US | disclosed |
| CN-116113404-A | Oligosaccharide compositions and methods of use thereof | DSM营养产品有限责任公司 | 2023-05-12 | — | — | CN | disclosed |
| CN-114901081-B | Malonyl steviol glycosides and edible use thereof | 弗门尼舍有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-114901081-A | Malonyl steviol glycosides and edible use thereof | 弗门尼舍有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-105814168-A | Improved gel stability | OMYA国际股份公司 | 2016-07-27 | — | — | CN | disclosed |
| US-20160008255-A1 | NON-AQUEOUS ORAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-14 | — | — | US | disclosed |
| WO-2015154691-A1 | A COMPOSITION COMPRISING ASTRAGALUS MEMBRANACEUS EXTRACT FOR PREVENTING/TREATING BRAIN INJURY AND ITS PREPARATION METHOD | PHYTOHEALTH CORPORATION (CN) | 2015-10-15 | — | — | WO | disclosed |
| EP-1535621-A1 | AGARICUS BLAZEI MURILL EXTRACT CAPABLE OF PREVENTING CANCER INDUCTION OR METASTASIS | Kyowa Engineering Co., Ltd. (JP) | 2005-06-01 | — | — | EP | disclosed |
| EP-1473038-A1 | METHOD OF PROTECTING LIVING BODY FROM FOREIGN FACTOR AND COMPOSITION THEREFOR | Sundory Co., Ltd. (JP) | 2004-11-03 | — | — | EP | disclosed |
| EP-0832898-A2 | Substituted amino acid derivatives | BAYER AG (DE) | 1998-04-01 | — | — | EP | disclosed |
| CN-1017900-B | PROCESS FOR PRODUCTION OF ELLIPTICINE DERIVATIVE | SUNTORY LTD (JP) | 1992-08-19 | — | — | CN | disclosed |
| CN-85107911-A | The production method of ellipticine derivative | — | 1987-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11766450-B2 | Use of polysaccharide for treating ST-elevation myocardial infarction and diseases of the digestion system | MGAM, GYS1, SI | THRB 2329/4885LMNA 1884/4885 |
| US-20240216417-A1 | Use of Polysaccharide for Treating ST-Elevation Myocardial Infarction and Diseases of the Digestion System | MGAM, GYS1, SI | THRB 2329/4885LMNA 1884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.